Sulfonylureas and platelet function.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  American Journal of Medicine

• Publication date

  1981-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(81)90585-4PMID 6782875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of cholesterol on production of thromboxane b2 by platelets in vitro.

  1980cited by this paper
• Relation of diabetic control to development of microvascular complications

  1978cited by this paper
• Platelet function and diabetes mellitus.

  1978cited by this paper
• Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973

  1978cited by this paper
• The Role of Endothelial Cell Injury and Platelet Response in Atherogenesis

  1977cited by this paper
• A hypothesis for the molecular mechanism of action of chlorpropamide in the treatment of diabetes mellitus and diabetes insipidus.

  1977cited by this paper
• An evaluation of the effects of some sulphonylureas on platelet function.

  1977cited by this paper
• Reversible hematologic sequelae of diabetes mellitus.

  1977cited by this paper
• Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.

  1977cited by this paper
• Altered platelet function in diabetes mellitus.

  1976cited by this paper
• Increased platelet aggregation in early diabetus mellitus.

  1975cited by this paper
• The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.

  1972cited by this paper
• Increased platelet aggregation in diabetes mellitus.

  1972cited by this paper
• Sulfonylureas: Effects in Vivo and in Vitro

  1971cited by this paper
• Platelet adhesiveness and aggregation in relation to diabetic retinopathy

  1971cited by this paper
• Platelet Aggregation and the Availability of Platelet Factor 3

  1966cited by this paper
• DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITIS.

  1964cited by this paper

• Fibrinogen, Coagulation, and Ageing.

  2023cites this paper
• Platelet-Neutrophil Interactions and Thrombo-inflammatory Complications in Type 2 Diabetes Mellitus

  2022cites this paper
• Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease

  2021influential citation
• The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation

  2018cites this paper
• Exposure to hypoglycemia and risk of stroke

  2018cites this paper
• Platelets and Hemostasis

  2018cites this paper
• Effects of oral hypoglycemic agents on platelet function.

  2015cites this paper
• Inflammation and thrombosis in diabetes

  2011cites this paper
• Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide

  2007cites this paper
• Cardiovascular disease prevention in patients with type 2 diabetes: the role of oral anti-diabetic agents

  2006cites this paper
• Gliquidone Contributes to Improvement of Type 2 Diabetes Mellitus Management

  2006cites this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  2005cites this paper
• Cardiovascular Risk Factors Associated with Insulin Resistance

  2005cites this paper
• Insulin Treatment in Type 2 Diabetes

  2001cites this paper
• Platelet dysfunction in type 2 diabetes.

  2001cites this paper
• Potassium channels participate in gastric mucosal protection in rats with partial portal vein ligation

  1998cites this paper
• Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

  1996cites this paper
• Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link

  1994cites this paper
• Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link.

  1994cites this paper
• The inhibitory effect of platelets on fibrinolysis in diabetic patients.

  1994cites this paper
• Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

  1993cites this paper
• Platelet abnormalities in diabetes mellitus.

  1993cites this paper
• Low molecular weight GTP-binding proteins are altered in platelet hyperaggregation in IDDM.

  1993cites this paper
• Diabetic Neuropathies

  1992cites this paper
• The Influence of Hypoglycaemic Agents on the Growth and Metabolism of Human Endothelial Cells

  1992cites this paper
• Pathophysiology of vascular disease in diabetes: effects of gliclazide.

  1991cites this paper
• Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.

  1988cites this paper
• Effect of Vitamin E Supplementation on Platelet Thromboxane A2 Production in Type I Diabetic Patients: Double-Blind Crossover Trial

  1988cites this paper
• Adverse Cardiovascular Effects of Sulphonylurea Drugs

  1987cites this paper
• [Oral antidiabetic agents including glucosidase inhibitors].

  1987cites this paper
• Decreased alpha 2-adrenergic receptors on platelet membranes from diabetic patients with autonomic neuropathy and orthostatic hypotension.

  1986cites this paper
• Platelet Behaviour in Non-Insulin-Dependent Diabetes -Influence of Vascular Complications, Treatment and Metabolic Control

  1986cites this paper
• The Second Generation Sulfonylureas: Glipizide and Glyburide

  1985cites this paper
• Glyburide: A Second‐generation Sulfonylurea Hypoglycemic Agent

  1985cites this paper
• [Effect of insulin and sulfonylurea derivatives on chronic intravascular microcoagulation of the blood in diabetes mellitus].

  1985cites this paper
• Tolbutamide effect on cultured human endothelial cells with special reference to platelet aggregation.

  1983cites this paper
• [Therapy with oral antidiabetics 1983].

  1983cites this paper
• Increased platelet aggregation in diabetes mellitus.

  1982cites this paper
• Aspirin failure in symptomatic atherosclerotic carotid artery disease.

  1981cites this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  1980cites this paper